Microbiome Sequencing Services Market Overview:
In this report, the global market is broadly segmented by technology, application, research type, laboratory type, end-user, and region. On the basis of technology, the market is divided into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing, and other technologies (such as Omic technologies). The sequencing by synthesis segment is expected to grow at the highest CAGR of the market in 2016.
The market by application is broadly classified into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole-genome sequencing, and other applications (such as small molecule analysis and protein analysis). The shotgun sequencing segment is estimated to grow at the highest CAGR and the highest share of the market during the forecast period.
In the technology segment, the major players are Clinical-Microbiomics A/S (Denmark), and Zymo Research Corp. (U.S.). These companies have a strong reputation and customer base.
Among these players in the technology segment, Clinical-Microbiomics A/S (Denmark) has strengthened its position in the market through the adoption of organic as well as inorganic strategies such as new product launches, service launches and agreements, collaborations, and partnerships. Between 2014 and 2017, the company introduced new services in its portfolio. For instance, in 2017, Clinical-Microbiomics A/S launched a new metagenomics platform for microbiome systems. This platform will reduce the cost of comprehensive whole-genome metagenomic profiling. Similarly, in 2016, partnered with Gubra ApS (Denmark) to focus on analyzing the role of the microbiome in conditions related to diabetes, obesity, and fatty liver disease.
Request For Sample:
Global Microbiome Sequencing Services, by Technology
Sequencing by Synthesis (SBS)
Sequencing by Ligation (SBL)
Other Technologies (Omic Technologies)
Global Microbiome Sequencing Services, by Application
Targeted Gene Sequencing
Whole Genome Sequencing
Other Applications (Protein analysis and small molecule analysis)
Global Microbiome Sequencing Services, by Research Type
Global Microbiome Sequencing Services, by Laboratory Type
Global Microbiome Sequencing Services, by End User
Pharmaceutical and Biotechnology Companies
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062